Annual Net Income
-$4.83 M
+$316.00 K+6.13%
March 31, 2024
Summary
- As of February 7, 2025, SNOA annual net profit is -$4.83 million, with the most recent change of +$316.00 thousand (+6.13%) on March 31, 2024.
- During the last 3 years, SNOA annual net income has fallen by -$885.00 thousand (-22.41%).
- SNOA annual net income is now -152.14% below its all-time high of $9.27 million, reached on March 31, 2017.
Performance
SNOA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$928.00 K
-$318.00 K-52.13%
December 31, 2024
Summary
- As of February 7, 2025, SNOA quarterly net profit is -$928.00 thousand, with the most recent change of -$318.00 thousand (-52.13%) on December 31, 2024.
- Over the past year, SNOA quarterly net income has dropped by -$62.00 thousand (-7.16%).
- SNOA quarterly net income is now -105.72% below its all-time high of $16.23 million, reached on December 31, 2016.
Performance
SNOA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$3.75 M
-$62.00 K-1.68%
December 31, 2024
Summary
- As of February 7, 2025, SNOA TTM net profit is -$3.75 million, with the most recent change of -$62.00 thousand (-1.68%) on December 31, 2024.
- Over the past year, SNOA TTM net income has increased by +$1.33 million (+26.16%).
- SNOA TTM net income is now -140.41% below its all-time high of $9.28 million, reached on March 31, 2017.
Performance
SNOA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
SNOA Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +6.1% | -7.2% | +26.2% |
3 y3 years | -22.4% | +29.1% | +27.2% |
5 y5 years | +59.0% | +29.1% | +27.2% |
SNOA Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -22.4% | +6.1% | -52.1% | +68.5% | -1.7% | +44.8% |
5 y | 5-year | -46.2% | +59.0% | -486.7% | +74.6% | -85.0% | +44.8% |
alltime | all time | -152.1% | +79.1% | -105.7% | +86.6% | -140.4% | +83.8% |
Sonoma Pharmaceuticals Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | - | -$928.00 K(+52.1%) | -$3.75 M(+1.7%) |
Sep 2024 | - | -$610.00 K(-46.6%) | -$3.69 M(-19.2%) |
Jun 2024 | - | -$1.14 M(+7.1%) | -$4.56 M(-5.7%) |
Mar 2024 | -$4.83 M(-6.1%) | -$1.07 M(+23.2%) | -$4.83 M(-4.7%) |
Dec 2023 | - | -$866.00 K(-41.6%) | -$5.08 M(-17.4%) |
Sep 2023 | - | -$1.48 M(+4.7%) | -$6.15 M(+8.2%) |
Jun 2023 | - | -$1.42 M(+8.4%) | -$5.68 M(+10.3%) |
Mar 2023 | -$5.15 M(+1.3%) | -$1.31 M(-32.5%) | -$5.15 M(-24.1%) |
Dec 2022 | - | -$1.94 M(+90.7%) | -$6.79 M(+17.2%) |
Sep 2022 | - | -$1.02 M(+14.7%) | -$5.79 M(+18.8%) |
Jun 2022 | - | -$887.00 K(-69.9%) | -$4.88 M(-4.1%) |
Mar 2022 | -$5.09 M(+28.8%) | -$2.94 M(+211.9%) | -$5.09 M(-12.3%) |
Dec 2021 | - | -$944.00 K(+844.0%) | -$5.80 M(+5.3%) |
Sep 2021 | - | -$100.00 K(-90.9%) | -$5.51 M(+4.2%) |
Jun 2021 | - | -$1.10 M(-70.0%) | -$5.29 M(+33.9%) |
Mar 2021 | -$3.95 M(+19.4%) | -$3.66 M(+463.1%) | -$3.95 M(+95.0%) |
Dec 2020 | - | -$650.00 K(-641.7%) | -$2.03 M(-17.6%) |
Sep 2020 | - | $120.00 K(-50.0%) | -$2.46 M(-35.0%) |
Jun 2020 | - | $240.00 K(-113.8%) | -$3.78 M(+14.4%) |
Mar 2020 | -$3.31 M(-72.0%) | -$1.74 M(+60.1%) | -$3.31 M(-31.0%) |
Dec 2019 | - | -$1.08 M(-9.9%) | -$4.79 M(-20.2%) |
Sep 2019 | - | -$1.20 M(-268.3%) | -$6.01 M(-21.2%) |
Jun 2019 | - | $715.00 K(-122.2%) | -$7.63 M(-35.4%) |
Mar 2019 | -$11.80 M(-17.7%) | -$3.22 M(+40.2%) | -$11.80 M(-11.6%) |
Dec 2018 | - | -$2.30 M(-18.5%) | -$13.34 M(-6.2%) |
Sep 2018 | - | -$2.82 M(-18.4%) | -$14.23 M(-0.4%) |
Jun 2018 | - | -$3.46 M(-27.4%) | -$14.28 M(-0.3%) |
Mar 2018 | -$14.33 M(-254.5%) | -$4.76 M(+49.5%) | -$14.33 M(+19.4%) |
Dec 2017 | - | -$3.19 M(+11.0%) | -$12.00 M(-261.9%) |
Sep 2017 | - | -$2.87 M(-18.2%) | $7.41 M(-11.0%) |
Jun 2017 | - | -$3.51 M(+44.0%) | $8.34 M(-10.1%) |
Mar 2017 | $9.27 M(-191.3%) | -$2.44 M(-115.0%) | $9.28 M(+5.4%) |
Dec 2016 | - | $16.23 M(-932.6%) | $8.80 M(-183.2%) |
Sep 2016 | - | -$1.95 M(-24.1%) | -$10.58 M(+1.8%) |
Jun 2016 | - | -$2.57 M(-11.8%) | -$10.39 M(+2.2%) |
Mar 2016 | -$10.16 M(+23.9%) | -$2.91 M(-7.6%) | -$10.16 M(+16.1%) |
Dec 2015 | - | -$3.15 M(+78.6%) | -$8.75 M(-24.0%) |
Sep 2015 | - | -$1.76 M(-24.7%) | -$11.52 M(+10.0%) |
Jun 2015 | - | -$2.34 M(+55.9%) | -$10.47 M(+27.7%) |
Mar 2015 | -$8.20 M(-319.6%) | -$1.50 M(-74.6%) | -$8.20 M(-1186.5%) |
Dec 2014 | - | -$5.91 M(+723.7%) | $755.00 K(-87.5%) |
Sep 2014 | - | -$718.00 K(+925.7%) | $6.06 M(+12.7%) |
Jun 2014 | - | -$70.00 K(-100.9%) | $5.38 M(+44.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2014 | $3.73 M(-168.8%) | $7.46 M(-1320.5%) | $3.73 M(-160.6%) |
Dec 2013 | - | -$611.00 K(-56.3%) | -$6.17 M(-17.4%) |
Sep 2013 | - | -$1.40 M(-18.3%) | -$7.47 M(-1.6%) |
Jun 2013 | - | -$1.71 M(-30.0%) | -$7.59 M(+39.7%) |
Mar 2013 | -$5.43 M(-25.9%) | -$2.44 M(+27.9%) | -$5.43 M(+14.2%) |
Dec 2012 | - | -$1.91 M(+25.9%) | -$4.75 M(-11.8%) |
Sep 2012 | - | -$1.52 M(-441.3%) | -$5.39 M(+14.4%) |
Jun 2012 | - | $445.00 K(-125.2%) | -$4.71 M(-35.7%) |
Mar 2012 | -$7.33 M(-7.8%) | -$1.77 M(-30.6%) | -$7.33 M(+1.0%) |
Dec 2011 | - | -$2.55 M(+203.6%) | -$7.25 M(+4.6%) |
Sep 2011 | - | -$839.00 K(-61.4%) | -$6.94 M(-10.5%) |
Jun 2011 | - | -$2.17 M(+28.4%) | -$7.75 M(-2.5%) |
Mar 2011 | -$7.95 M(-3.4%) | -$1.69 M(-24.0%) | -$7.95 M(+3.1%) |
Dec 2010 | - | -$2.23 M(+35.2%) | -$7.71 M(+13.0%) |
Sep 2010 | - | -$1.65 M(-30.6%) | -$6.82 M(-3.5%) |
Jun 2010 | - | -$2.38 M(+63.6%) | -$7.07 M(-14.2%) |
Mar 2010 | -$8.23 M(-53.4%) | -$1.45 M(+7.9%) | -$8.23 M(-8.6%) |
Dec 2009 | - | -$1.35 M(-28.9%) | -$9.01 M(-18.0%) |
Sep 2009 | - | -$1.89 M(-46.5%) | -$10.98 M(-31.4%) |
Jun 2009 | - | -$3.54 M(+59.1%) | -$16.00 M(-9.4%) |
Mar 2009 | -$17.66 M(-13.2%) | -$2.23 M(-33.0%) | -$17.66 M(-11.3%) |
Dec 2008 | - | -$3.32 M(-52.0%) | -$19.91 M(-9.1%) |
Sep 2008 | - | -$6.91 M(+32.9%) | -$21.89 M(+6.7%) |
Jun 2008 | - | -$5.20 M(+16.2%) | -$20.52 M(+0.9%) |
Mar 2008 | -$20.34 M(+2.8%) | -$4.47 M(-15.6%) | -$20.34 M(-8.2%) |
Dec 2007 | - | -$5.30 M(-4.3%) | -$22.16 M(+2.2%) |
Sep 2007 | - | -$5.54 M(+10.4%) | -$21.68 M(+5.7%) |
Jun 2007 | - | -$5.02 M(-20.2%) | -$20.50 M(+3.5%) |
Mar 2007 | -$19.78 M(-14.4%) | -$6.29 M(+30.3%) | -$19.82 M(-1.9%) |
Dec 2006 | - | -$4.83 M(+10.5%) | -$20.21 M(-8.4%) |
Sep 2006 | - | -$4.37 M(+0.8%) | -$22.06 M(-2.2%) |
Jun 2006 | - | -$4.33 M(-35.1%) | -$22.56 M(-2.3%) |
Mar 2006 | -$23.10 M(+39.7%) | -$6.68 M(-0.0%) | -$23.10 M(+12.4%) |
Dec 2005 | - | -$6.68 M(+37.1%) | -$20.55 M(+14.1%) |
Sep 2005 | - | -$4.87 M(0.0%) | -$18.01 M(+4.3%) |
Jun 2005 | - | -$4.87 M(+17.9%) | -$17.27 M(+4.5%) |
Mar 2005 | -$16.53 M(+126.5%) | -$4.13 M(-0.0%) | -$16.53 M(+33.3%) |
Dec 2004 | - | -$4.13 M(0.0%) | -$12.40 M(+50.0%) |
Sep 2004 | - | -$4.13 M(0.0%) | -$8.27 M(+100.0%) |
Jun 2004 | - | -$4.13 M | -$4.13 M |
Mar 2004 | -$7.30 M(+357.6%) | - | - |
Mar 2003 | -$1.59 M(+855.1%) | - | - |
Mar 2002 | -$167.00 K | - | - |
FAQ
- What is Sonoma Pharmaceuticals annual net profit?
- What is the all time high annual net income for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals annual net income year-on-year change?
- What is Sonoma Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals quarterly net income year-on-year change?
- What is Sonoma Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Sonoma Pharmaceuticals?
- What is Sonoma Pharmaceuticals TTM net income year-on-year change?
What is Sonoma Pharmaceuticals annual net profit?
The current annual net income of SNOA is -$4.83 M
What is the all time high annual net income for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high annual net profit is $9.27 M
What is Sonoma Pharmaceuticals annual net income year-on-year change?
Over the past year, SNOA annual net profit has changed by +$316.00 K (+6.13%)
What is Sonoma Pharmaceuticals quarterly net profit?
The current quarterly net income of SNOA is -$928.00 K
What is the all time high quarterly net income for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high quarterly net profit is $16.23 M
What is Sonoma Pharmaceuticals quarterly net income year-on-year change?
Over the past year, SNOA quarterly net profit has changed by -$62.00 K (-7.16%)
What is Sonoma Pharmaceuticals TTM net profit?
The current TTM net income of SNOA is -$3.75 M
What is the all time high TTM net income for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals all-time high TTM net profit is $9.28 M
What is Sonoma Pharmaceuticals TTM net income year-on-year change?
Over the past year, SNOA TTM net profit has changed by +$1.33 M (+26.16%)